The global histology and cytology market is expected to grow at a CAGR of around 12.8% from 2020 to 2027 and expected to reach the market value of around US$ 39.8 Bn by 2027
Cytology is a branch of biology which studies detailed examination of individual cells in both plants and animals including human beings; whereas histology is the study of cell internal characteristics under the microscope. These tests are majorly done to detect and treat infectious diseases and cancer. The examination is executed by placing the sample cell or tissue under a digital or electronic microscope. Cancer is the second major cause of death after cardiovascular diseases. Early detection of cancer and risk factors would improve prevention, survival rate and quality of human being lives. According to World Health Organization, cancer is one of the leading causes of morbidity and mortality after cardiovascular diseases across the globe, accounting for around 9.5 million deaths in 2018. Huge increase in the prevalence of cancer, technological augmentations in diagnostic and molecular methods, rising standardization of pathological laboratories and favorable reimbursements for cancer screening and laboratory tests are the factors responsible for the high CAGR of the market during the forecast period.
According to International Agency for Research, 2020 Cancer is responsible for 8.51 lakh deaths in India every year. As per World Health Organization (WHO), one in 10 Indians will develop cancer during their lifetime, and one in 15 will die of cancer. According to the American Cancer Society, an estimated 81,000 cases of bladder cancer will be diagnosed in the U.S in 2021. Accurate detection of bladder cancer, or urothelial carcinoma (UC), is often difficult and expensive, requiring invasive camera-based testing methodology. Cytology and Histology are quite popular and demand methods for diagnosing such cancers.
Market Dynamics
The surge in well-equipped diagnostic systems and favourable reimbursement for cancer screening and laboratory test is having a positive effect on market growth. The factors contributing to market growth include increasing incidence and prevalence of cancer due to lifestyle changes, development of advanced tools for early disease diagnosis, execution of immunohistochemistry, and innovation in microscopy examination. Collaboration of healthcare organizations & research institutions with the standardization of cytopathology across the world, is driving the market. The integration of digital solutions to cytology offers the advantage of the rapid interpretation of primary diagnostic data. Continuous R&D efforts and investment by industry players broaden the scope of its application in disease diagnosis. Furthermore, conducting awareness programs about cancer will boost business revenue even further. However, the high cost of diagnosis may limit the growth of the histology & cytology market in the coming years.
Segment Analysis by Region
The global histology & cytology market has been divided into five major regions: North America, Europe, APAC, LATAM, and Middle East & Africa. North America is dominating the market for the entire forecast period followed by Europe. North America region is projected to accelerate the growth of the market due to an increase in the prevalence of cancer. Technological advancements and innovation towards early detection of disease in this particular region expected to fuel the growth of the market. India and China in the APAC region are expected to have the fastest growth in the market due to the presence of a large patient pool and population in the region suffering from various infectious diseases will benefit regional growth. In the coming years, regional business growth will be accelerated by rising demand for efficient sample testing, early diagnosis and government involvement which will result in timely treatment and faster patient outcomes.
Covid-19 Impact on Global Histology and Cytology Market:
The strategic collaboration is being observed between many companies for developing antibodies specific for validation with immunohistochemistry. For instance, GeneTex, Inc., a leading research antibody manufacturer, has developed the most comprehensive and well-characterized catalogue of SARS-CoV-2 reagents for researchers. To further optimize these antibodies, GeneTex has partnered with HistoWiz, Inc., which specializes in histopathological services. The first phase of this collaboration has established several highly validated antibodies for immunohistochemistry (IHC) on human SARS-CoV-2-infected tissues.
The pandemic has become a stimulating factor for changing traditional pathology workflows with the integration of Artificial Intelligence (AI) and digitalization solutions for early diagnosis and treatment. During the pandemic, these methods have been assisted many healthcare professionals to understand the results virtually.
Competitive Landscape
Roche, BD, 3DHISTECH, Abbott Laboratories, Danaher, are the major key players in the cytology and histology market. And some other major players in the global market for histology and cytology are trying to bring automated digital imaging solutions that can enhance the rapid results Many companies are focusing on developing economies where there is huge untapped revenue potential outstanding to improved healthcare infrastructure in recent years. The top key players in the market are F.Hoffmann-La Roche, Hologic, Inc., Becton, Dickinson & Company, Merck KGaA, Danaher Corporation, Abbott Laboratories, Philips Healthcare, Sysmex Corporation, Koninklijke, and Trivitron Healthcare. Mergers and acquisitions among the top key players are key strategies to propel the market next level.
Histology and Cytology Market Segment Analysis, 2021
The Global Histology and Cytology market is segmented into Examination Type, Product Type, Application and Region. The Examination type is further subdivided into Histology and Cytology. The Test type is segregated as Instruments and Analysis Software systems. And the Application is further segmented into Hospitals, Diagnostic centers, Research institutes and others.
Market Segmentation
Market By Type Of Examination
Histology
- Microscopy Technique
- Immunohistochemistry Technique
- Molecular pathology Technique
- Cryostat & Microtomy Technique
Cytology
- Breast Cancer
- Cervical Cancer
- Bladder Cancer
- Lung Cancer
- Other Cancers
Market By Product
Instruments and Analysis Software System
Consumable and Reagents
Market By Application
Drug Discovery & Designing
Clinical Diagnostics
Research
Market By Geography
North America
• U.S.
• Canada
Europe
• U.K.
• Germany
• France
• Spain
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Histology and Cytology Market
1.1. Definition and Scope
1.1.1. Definition of Histology and Cytology Market
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Histology and Cytology Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Histology and Cytology Market By Type of Examination
1.2.3. Histology and Cytology Market By Product
1.2.4. Histology and Cytology Market By Application
1.2.5. Histology and Cytology Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Histology and Cytology Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Histology and Cytology Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Histology and Cytology Market By Type of Examination
4.1. Introduction
4.2. Histology and Cytology Market Revenue By Type of Examination
4.2.1. Histology and Cytology Market Revenue (US$ Mn) and Forecast, By Type of Examination, 2021-2027
4.2.2. Microscopy Technique
4.2.2.1. Microscopy Technique Market Revenue (US$ Mn) and Growth Rate (%), 2021-2027
4.2.3. Immunohistochemistry Technique
4.2.3.1. Immunohistochemistry Technique Market Revenue (US$ Mn) and Growth Rate (%), 2021-2027
4.2.4. Molecular pathology Technique
4.2.4.1 Molecular pathology Technique Market Revenue (US$ Mn) and Growth Rate (%), 2021-2027
4.2.5. Cryostat &Microtomy Technique
4.2.5.1 Cryostat &Microtomy Technique Market Revenue (US$ Mn) and Growth Rate (%), 2021-2027
CHAPTER 5. Histology and Cytology Market Revenue By Product
5.1. Introduction
5.2. Histology and Cytology Market Revenue (US$ Mn)By Product
5.2.1. Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
5.2.2. Instruments and Analysis Software System
5.2.2.1. Instruments and Analysis Software System Market Revenue (US$ Mn) and Growth Rate (%), 2021-2027
5.2.3. Consumable and Reagents
5.2.3.1. Consumable and Reagents Market Revenue (US$ Mn) and Growth Rate (%), 2021-2027
5.2.4. Others
5.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2021-2027
CHAPTER 6. Histology and Cytology Market By Application
6.1. Introduction
6.2. Histology and Cytology Market Revenue (US$ Mn) By Application
6.2.1. Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
6.2.2. Hospital/clinics
6.2.2.1. Hospital/clinics Market Revenue (US$ Mn) and Growth Rate (%), 2021-2027
6.2.3. Diagnostic centers/Laboratories
6.2.3.1. Diagnostic centers/Laboratories Market Revenue (US$ Mn) and Growth Rate (%), 2021-2027
6.2.4. Research institutes
6.2.4.1. Research institutes Market Revenue (US$ Mn) and Growth Rate (%), 2021-2027
6.2.5. Others
6.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2021-2027
CHAPTER 7. North America Histology and Cytology Market By Country
7.1. North America Histology and Cytology Market Overview
7.2. U.S.
7.2.1. U.S. Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
7.2.2. U.S. Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
7.2.3. U.S. Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
7.3. Canada
7.3.1. Canada Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
7.3.2. Canada Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
7.3.3. Canada Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Histology and Cytology Market By Country
8.1. Europe Histology and Cytology Market Overview
8.2. U.K.
8.2.1. U.K. Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
8.2.2. U.K. Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
8.2.3. U.K. Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
8.3. Germany
8.3.1. Germany Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
8.3.2. Germany Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
8.3.3. Germany Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
8.4. France
8.4.1. France Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
8.4.2. France Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
8.4.3. France Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
8.5. Spain
8.5.1. Spain Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
8.5.2. Spain Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
8.5.3. Spain Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
8.6.2. Rest of Europe Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
8.6.3. Rest of Europe Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Histology and Cytology Market By Country
9.1. Asia Pacific Histology and Cytology Market Overview
9.2. China
9.2.1. China Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
9.2.2. China Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
9.2.3. China Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
9.3. Japan
9.3.1. Japan Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
9.3.2. Japan Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
9.3.3. Japan Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
9.4. India
9.4.1. India Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
9.4.2. India Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
9.4.3. India Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
9.5. Australia
9.5.1. Australia Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
9.5.2. Australia Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
9.5.3. Australia Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
9.6. South Korea
9.6.1. South Korea Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
9.6.2. South Korea Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
9.6.3. South Korea Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
9.7.2. Rest of Asia-Pacific Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
9.7.3. Rest of Asia-Pacific Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Histology and Cytology Market By Country
10.1. Latin America Histology and Cytology Market Overview
10.2. Brazil
10.2.1. Brazil Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
10.2.2. Brazil Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
10.2.3. Brazil Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
10.3. Mexico
10.3.1. Mexico Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
10.3.2. Mexico Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
10.3.3. Mexico Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
10.4.2. Rest of Latin America Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
CHAPTER 11. Middle East & Africa Histology and Cytology Market By Country
11.1. Middle East & Africa Histology and Cytology Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
11.2.2. Saudi Arabia Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
11.2.3. Saudi Arabia Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
11.3. UAE
11.3.1. UAE Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
11.3.2. UAE Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
11.3.3. UAE Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Histology and Cytology Market Revenue (US$ Mn) and Forecast By Type of Examination, 2021-2027
11.4.2. Rest of Middle East & Africa Histology and Cytology Market Revenue (US$ Mn) and Forecast By Product, 2021-2027
11.4.3. Rest of Middle East & Africa Histology and Cytology Market Revenue (US$ Mn) and Forecast By Application, 2021-2027
CHAPTER 12. PLAYER ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET
12.1. Histology and Cytology Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Histology and Cytology Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. COMPANY PROFILE
13.1.1. F.Hoffmann-La Roche
13.1.2. Company Snapshot
13.1.3. Business Overview
13.1.4. Financial Overview
13.1.4.1. Revenue (US$ Mn), 2019
13.1.4.2. F.Hoffman-La Roche2021Histology and Cytology Market Business Regional Distribution
13.1.5. Product/ Service and Specification
13.1.6. Recent Developments& Business Strategy
13.1.7. Manufacturing Plant Footprint Analysis
13.2. Thermo Fisher Scientific Inc.
13.3. Hologic, Inc.
13.4. Becton Dickinson & Company
13.5. Merck KGaA
13.6. Danaher Corporation
13.7. Abbott Laboratories
13.8. Philips Healthcare
13.9. Trivitron Healthcare
13.10. Sysmex Corporation
13.11. Koninklijke
13.12. Others
